CDEK
← All organizations

Myovant Sciences GmbH

For profitWebsite ↗

Also known as: Myovant Sciences | MYOVANT SCIENCES | Myovant Sciences GmbH

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jun 16, 2016

First marketed drug

Dec 18, 2020

Last known activity

Aug 12, 2024

Acquired by Sumitomo Dainippon on Sep 6, 2019

Timeline

2010s

  1. Jun 1, 2016

    Myovant Sciences GmbH— Founded

  2. Sep 6, 2019

    Sumitomo Dainippon— Acquired By

2020s

  1. Dec 18, 2020

    relugolix— Marketing Organization

  2. May 26, 2021

    estradiol— NDA Secondary Org

Drugs by trial phase (8 distinct, 17 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Recent trials (23)

Details

Founded
London, GB Jun 1, 2016
Last known activity
Aug 12, 2024